LILLEY'SVPHARMACOLOGYVFORVCANADIANVHEALTHVCAREVPRACTICE
KARAVSEALOCK
4th Edition
V
TESTBANK V
, V
lOMoAR cPSD|
V 3013804
V V
lOMoAR cPSD| 3013804
Chapter 01: Nursing Practice in Canada and Drug Therapy
V V V V V V V V
Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition
V V V V V V V V V
MULTIPLEVCHOICE
1. WhichVisVaVjudgementVaboutVaVparticularVpatient’sVpotentialVneedVorVproblem?
a. AVgoal
b. AnVassessment
c. SubjectiveVdata
d. AVnursingVdiagnosis
ANS:V D
NursingVdiagnosisVisVtheVphaseVofVtheVnursingVprocessVduringVwhichVaVclinicalVjudgementVisVmadeVabou
VheathVconditionsVandVlifeVprocessesVorVvulnerabilityVforVthatVresponse.
DIF: CognitiveVLevel:VKnowledge
2. TheVpatientVisVtoVreceiveVoralVfurosemideV(Lasix)VeveryVday;Vhowever,VbecauseVtheVpatientVisVunableVto
keVmedicationVorally,VasVordered.VTheVnurseVneedsVtoVcontactVtheVphysician.VWhatVtypeVofVproblemVisVt
a. AV“rightVtime”Vproblem
b. AV“rightVdose”Vproblem
c. AV“rightVroute”Vproblem
d. AV“rightVmedication”Vproblem
ANS:V C
ThisVisVaV“rightVroute”Vproblem:VtheVnurseVcannotVassumeVtheVrouteVandVmustVclarifyVtheVrouteVwithVthe
ghtVtime”VproblemVbecauseVtheVorderedVfrequencyVhasVnotVchanged.VThisVisVnotVaV“rightVdose”Vproblem
atedVtoVanVinabilityVtoVswallow.VThisVisVnotVaV“rightVmedication”VproblemVbecauseVtheVmedicationVorde
Vroute.
DIF: CognitiveVLevel:VApplication
3. TheVnurseVhasVbeenVmonitoringVtheVpatient’sVprogressVonVhisVnewVdrugVregimenVsinceVtheVfirstVdoseVand
nsVofVpossibleVadverseVeffects.VWhatVnursingVprocessVphaseVisVtheVnurseVpractising?
a. Planning
b. Evaluation
c. Implementation
d. NursingVdiagnosis
ANS:V B
MonitoringVtheVpatient’sVprogressVisVpartVofVtheVevaluationVphase.VPlanning,Vimplementation,VandVnursi
tedVbyVthisVexample.
DIF: CognitiveVLevel:VApplication
4. TheVnurseVisVcaringVforVaVpatientVwhoVhasVbeenVnewlyVdiagnosedVwithVtypeV1VdiabetesVmellitus.VWhichV
anVoutcomeVcriterionVforVthisVpatient?
a. TheVpatientVwillVfollowVinstructions.
b. TheVpatientVwillVnotVexperienceVcomplications.
c. TheVpatientVadheresVtoVtheVnewVinsulinVtreatmentVregimen.
d. TheVpatientVdemonstratesVsafeVinsulinVself-administrationVtechnique.
ANS:V D
HavingVtheVpatientVdemonstrateVsafeVinsulinVself-
administrationVtechniqueVisVaVspecificVandVmeasurableVoutcomeVcriterion.VFollowingVinstructionsVandVa
otVspecificVcriteria.VAdherenceVtoVtheVnewVinsulinVtreatmentVregimenVisVnotVobjectiveVandVwouldVbeVdif
, V
lOMoAR cPSD|
V 3013804
6. TheVnurseVisVworkingVduringVaVveryVbusyVnightVshift,VandVtheVhealthVcareVproviderVhasVjustVgivenVtheVnu
verVtheVtelephone,VbutVtheVnurseVdoesVnotVrecallVtheVroute.VWhatVisVtheVbestVwayVforVtheVnurseVtoVavoid
a. RecopyVtheVorderVneatlyVonVtheVorderVsheet,VwithVtheVmostVcommonVrouteVindicated
b. ConsultVwithVtheVpharmacistVforVclarificationVaboutVtheVmostVcommonVroute
c. CallVtheVhealthVcareVproviderVtoVclarifyVtheVrouteVofVadministration
d. WithholdVtheVdrugVuntilVtheVhealthVcareVproviderVvisitsVtheVpatient
ANS:VC
IfVaVmedicationVorderVdoesVnotVincludeVtheVroute,VtheVnurseVmustVaskVtheVhealthVcareVproviderVtoVclarify
dministration.
DIF: CognitiveVLevel:VApplicationV|VCognitiveVLevel:VAnalysis
7. WhichVconstitutesVtheVtraditionalVFiveVRightsVofVmedicationVadministration?
a. RightVdrug,VrightVroute,VrightVdose,VrightVtime,VandVrightVpatient
b. RightVdrug,VtheVrightVeffect,VtheVrightVroute,VtheVrightVtime,VandVtheVrightVpatient
c. RightVpatient,VrightVstrength,VrightVdiagnosis,VrightVdrug,VandVrightVroute
d. RightVpatient,VrightVdiagnosis,VrightVdrug,VrightVroute,VandVrightVtime
ANS:VA
TheVtraditionalVFiveVRightsVofVmedicationVadministrationVwereVconsideredVtoVbeVRightVdrug,VRightVrou
RightVpatient.VRightVeffect,VrightVstrength,VandVrightVdiagnosisVareVnotVpartVofVtheVtraditionalVFiveVRigh
DIF: CognitiveVLevel:VComprehension
8. WhatVcorrectlyVdescribesVtheVnursingVprocess?
a. Diagnosing,Vplanning,Vassessing,Vimplementing,VandVfinallyVevaluating
b. Assessing,VthenVdiagnosing,Vimplementing,VandVendingVwithVevaluating
c. AVlinearVdirectionVthatVbeginsVwithVassessingVandVcontinuesVthroughVdiagnosin
g,Vplanning,VandVfinallyVimplementing
d. AnVongoingVprocessVthatVbeginsVwithVassessingVandVcontinuesVwithVdiagnosin
g,Vplanning,Vimplementing,VandVevaluating
ANS:VD
TheVnursingVprocessVisVanVongoing,Vflexible,Vadaptable,VandVadjustableVfive-
stepVprocessVthatVbeginsVwithVassessingVandVcontinuesVthroughVdiagnosing,Vplanning,Vimplementing,Van
VmayVthenVleadVbackVtoVanyVofVtheVotherVphases.
DIF: CognitiveVLevel:VApplication
9. WhenVtheVnurseVisVconsideringVtheVtimingVofVaVdrugVdose,VwhichVisVmostVimportantVtoVassess?
a. TheVpatient’sVidentification
b. TheVpatient’sVweight
c. TheVpatient’sVlastVmeal
d. AnyVdrugVorVfoodVallergies
ANS:VC
TheVpharmacokineticVandVpharmacodynamicVpropertiesVofVtheVdrugVneedVtoVbeVassessedVwithVregardVto
foodVinteractionsVorVcompatibilityVissues.VTheVpatient’sVidentification,Vweight,VandVdrugVorVfoodVallergi
Vtiming.
DIF: CognitiveVLevel:VApplication
10. TheVnurseVisVwritingVnursingVdiagnosesVforVaVplanVofVcare.VWhichVreflectsVtheVcorrectVformatVforVherVnu
a. Anxiety
b. AnxietyVrelatedVtoVnewVdrugVtherapy
c. AnxietyVrelatedVtoVanxiousVfeelingsVaboutVdrugVtherapy,VasVevidencedVb
yVstatementsVsuchVasV“I’mVupsetVaboutVhavingVtoVgiveVmyselfVshots”
d. AnxietyVrelatedVtoVnewVdrugVtherapy,VasVevidencedVbyVstatementsVsuchVasV“I’
mVupsetVaboutVhavingVtoVgiveVmyselfVshots”
, V
lOMoAR cPSD|
V 3013804
DIF: CognitiveVLevel:VAnalysis